https://www.selleckchem.com/pr....oducts/Dexamethasone
Combination therapy with somatostatin receptor ligand (SRL) plus pegvisomant for patients with acromegaly is recommended after a maximizing dose on monotherapy. Lower-dose combination regimens are not well studied. To compare cost-effectiveness and efficacy of 3 lower-dose combination regimens in controlled and uncontrolled acromegaly. Prospective, randomized, open-label, parallel arm study at a tertiary referral pituitary center. Adults with acromegaly regardless of response to prior SRL and biochemical control status at baseline
Like
Comment
Share
